Patents by Inventor Tetyana Kirpenko

Tetyana Kirpenko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface
    Publication number: 20100129343
    Abstract: The present invention is directed to the use of a compound stimulating deubiquitinating activity in a cell for the manufacture of a medicament for enhancing the expression of integral membrane proteins on the cell surface. Especially, the invention is directed to the use of such compound for the manufacture of a medicament for the treatment of a disease of condition selected from the group consisting of cystic fibrosis, diabetes insipidus, hypercholesterinaemia and long QT-syndrome-2.
    Type: Application
    Filed: January 27, 2010
    Publication date: May 27, 2010
    Applicant: Axentis Pharma AG
    Inventors: Michael Freissmuth, Tetyana Kirpenko, Christian Nanoff, Volodymyr M. Korkhov
  • Use of a compound for enhancing the expression of membrane proteins on the cell surface
    Publication number: 20070218043
    Abstract: The present invention is directed to the use of a compound stimulating deubiquitinating activity in a cell for the manufacture of a medicament for enhancing the expression of integral membrane proteins on the cell surface. Especially, the invention is directed to the use of such compound for the manufacture of a medicament for the treatment of a disease of condition selected from the group consisting of cystic fibrosis, diabetes insipidus, hypercholesterinaemia and long QT-syndrome-2.
    Type: Application
    Filed: January 5, 2007
    Publication date: September 20, 2007
    Inventors: Michael Freissmuth, Tetyana Kirpenko, Christian Nanoff, Volodymyr Korkhov
  • Use of a compound for enhancing the expression of membrane proteins on the cell surface
    Publication number: 20060008454
    Abstract: The present invention is directed to the use of a compound stimulating deubiquitinating activity in a cell for the manufacture of a medicament for enhancing the expression of integral membrane proteins on the cell surface. Especially, the invention is directed to the use of such compound for the manufacture of a medicament for the treatment of a disease of condition selected from the group consisting of cystic fibrosis, diabetes insipidus, hypercholesterinaemia and long QT-syndrome-2.
    Type: Application
    Filed: July 7, 2004
    Publication date: January 12, 2006
    Inventors: Michael Freissmuth, Tetyana Kirpenko, Christian Nanoff